Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
5.45
+0.20 (3.81%)
Jul 17, 2026, 4:00 PM EDT - Market closed
Zura Bio Market Cap
Zura Bio has a market cap or net worth of $517.74 million as of July 17, 2026. Its market cap has increased by 548.64% in one year.
Market Cap
517.74M
Enterprise Value
292.14M
1-Year Change
548.64%
Ranking
Category
Stock Price
$5.45
ChartMarket Cap Chart
Since September 3, 2021, Zura Bio's market cap has increased from $167.33M to $517.74M, an increase of 209.42%. That is a compound annual growth rate of 26.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 517.74M | 51.95% |
| Dec 31, 2025 | 340.72M | 108.73% |
| Dec 31, 2024 | 163.23M | -19.82% |
| Dec 29, 2023 | 203.58M | 15.59% |
| Dec 30, 2022 | 176.12M | 3.44% |
| Dec 31, 2021 | 170.26M | 1.75% |
| Sep 3, 2021 | 167.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Relmada Therapeutics | 549.62M |
| Contineum Therapeutics | 532.01M |
| Assembly Biosciences | 531.30M |
| Verastem | 529.88M |
| Eikon Therapeutics | 528.93M |
| Arvinas | 516.81M |
| Ginkgo Bioworks Holdings | 516.72M |
| REGENXBIO | 511.30M |